Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) Study, Biomarker and Health Service Research Analyses

NCT05007353 is registered in ClinicalTrials.gov with National University of Singapore as lead sponsor.

NCT NCT05007353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05007353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) Study, Biomarker and Health Service Research Analyses
Lead sponsor
National University of Singapore
Phase
Not applicable
Overall status
Completed
Start date
August 23, 2021
Completion date
December 29, 2025
Enrollment
1,212 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, brain diseases, central nervous system diseases, cognition disorder, cognitive impairment, dementia, mental disorders, nervous system diseases, neurocognitive disorders, vascular cognitive impairment